Results 1 to 10 of about 19,123 (184)
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
Aptamers are short single-strand oligonucleotides that can form secondary and tertiary structures, fitting targets with high affinity and specificity.
Yongshu Li +13 more
doaj +3 more sources
Probing three-dimensional cyclooctatetraene for nucleobase modification in aptamer selection [PDF]
Decoration of aptamers with chemical modifications at the level of nucleobases grants access to alternative binding modes, which often result in improved binding properties.
Greta Charlotte Dahm +9 more
doaj +2 more sources
Sequence optimization of a DNA aptamer inhibiting COVID-19 infection guided by analysis of secondary structure distribution [PDF]
The post-SELEX optimization of nucleic acid aptamers is often hindered by conformational ambiguity, as the specific functional structure is typically unknown.
Maria Izabel Muniz +10 more
doaj +2 more sources
The Diagnostic and Therapeutic Potential of Oligonucleotide Aptamers in Alzheimer’s Disease [PDF]
Alzheimer’s disease (AD) is the neurodegenerative condition with the outmost future challenges, with timely diagnosis and treatment being the most urgent.
Georgios Katsipis +3 more
doaj +2 more sources
The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing -(1 -pentynyl)-2′-deoxyuridine [PDF]
Combinatorial libraries of nucleic acids are developing into novel sources for lead compounds in drug development. In order to diversify the pool of ss DNA sequences, we have used a modified nucleotide, 5-(1-pentynyl)-2'-deoxyuridine, in place of thymidine in a random nucleic acid library and screened this library against human thrombin. Previously, we
John A. Latham +2 more
openaire +2 more sources
Nucleotide Bias Observed with a Short SELEX RNA Aptamer Library [PDF]
Systematic evolution of ligands by exponential enrichment (SELEX) is a powerful in vitro selection process used for over 2 decades to identify oligonucleotide sequences (aptamers) with desired properties (usually high affinity for a protein target) from randomized nucleic acid libraries.
William H, Thiel +12 more
openaire +2 more sources
The causative agent of COVID-19, SARS-CoV-2, gains access to cells through interactions of the receptor-binding domain (RBD) on the viral S protein with angiotensin-converting enzyme 2 (ACE2) on the surface of human host cells.
Irani Alves Ferreira-Bravo +1 more
doaj +1 more source
PPAI: a web server for predicting protein-aptamer interactions
Background The interactions between proteins and aptamers are prevalent in organisms and play an important role in various life activities. Thanks to the rapid accumulation of protein-aptamer interaction data, it is necessary and feasible to construct an
Jianwei Li +3 more
doaj +1 more source
DNA aptamer against EV-A71 VP1 protein: selection and application
Background Enterovirus 71 (EV-A71) is a highly infectious pathogen associated with hand, foot and mouth disease, herpangina, and various neurological complications, so it is important for the early detection and treatment of EV-A71.
Xinran Zou +4 more
doaj +1 more source
Aptamers, the nucleic acid analogs of antibodies, bind to their target molecules with remarkable specificity and sensitivity, making them promising diagnostic and therapeutic tools. The systematic evolution of ligands by exponential enrichment (SELEX) is
Ashraf M. Muhammad +5 more
doaj +1 more source

